company tower banner
ABITEC Corporation Company Logo
These functional lipid excipients act as solubilizers and emulsifiers in oral drug delivery systems. CAPMUL excipients are recognized as the ideal starting point when formulating BCS Class II & IV (poorly water soluble) and BCS Class III & IV (poorly permeable) molecules. Lipid-based drug delivery systems may be formulated as liquid or semi-solid formulations for oral dosage forms. It is manufactured in USA.

Chemical Name: Glyceryl Monocaprylate

Functions: Binder, Bioavailability Enhancer, Controlled Release Agent, Emulsifier, Encapsulant, Penetration Enhancer, Solubilizer

Dosage Form: Capsules, Creams, Injectables, Lotions, Ointments, Tablets

Labeling Claims: Aflatoxin-free, BSE-free, CMR Substances-free, Clean Label, Non-GMO, Polychlorinated Biphenyls (PCB)-free, TSE-free, Vegan

Certifications & Compliance: BRC Certified, FDA Compliant, GFSI Certified, GMP, Generally Recognized As Safe (GRAS), Hazard Analysis Critical Control Point (HACCP), ISO 45001, ISO 9001

  • TypeDocument Name
View All Documents

Knowde Enhanced TDS

Identification & Functionality

CAS No.
93906-96-8

Features & Benefits

Product Highlights

Processing Aids

  • Direct-compression, free-fraction tablet lubricants which reduce ejection force but allow for faster disintegration times than surface spreading lubricants
  • Soft gel lubricants which allow for less washing and ease of capsule printing
  • Binder excipients for hot melt granulation and extrusion

Emulsification

  • Functional lipids for primary and secondary emulsification of actives
  • Emulsifiers and surfactants for the formulation of self-emulsifying drug delivery systems (SEDDS)

Lipid Nanoparticle Delivery Systems

  • Functional lipids for the development of solid lipid nanoparticles and nanostructured lipids

Permeation Enhancement

  • Functional lipids which can increase the permeation of BCS Class III and BCS Class IV actives
  • Increase permeation of polar molecules with functional groups which are ionized at biological pH
  • Increase permeation of actives affected by PGP mediated efflux

Controlled Release

  • Formulation of both matrix and encapsulated controlled release
  • Formulation of controlled release multi-particulates for use in tablet and capsule formulations
  • Directly-compressed matrix controlled release tablet formulations

Encapsulation

  • Formulation of functional multi-particulates
  • Use in both matrix and encapsulated multi-particulates
  • Employ in both congealing and molten fluid bed unit operations

Applications & Uses

Manufacturing Technology
Applications
  • Solubilization

Properties

Physical Form
Typical Properties
ValueUnitsTest Method / Conditions
CBD Solubility (Visual)40%w/w
Solubilization
  • Increase the solubility of BCS Class II and BCS Class IV actives
  • Increase the bioavailability of poorly water-soluble actives
  • Both single lipid and self-emulsifying drug delivery system (SEDDS) formulations of poorly water soluble APIs

Regulatory & Compliance

Regulatory Status

EP, USP/NF

Packaging & Availability

Packaging Type